Contera Pharma will receive an upfront payment and full research funding for each target under investigation
Skyhawk Therapeutics enters into an option agreement to grant Merck KGaA, Darmstadt, Germany, exclusive global rights to drug candidates pursued under the collaboration upon option exercise
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
New Centre of Excellence at Electronic City campus to offer specialised care in epilepsy, cerebrovascular disorders, neurointervention, skull base and spine surgery
The system is powered by BrainSense technology, which has received approval from USFDA
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
